Latest Insider Transactions at Medifast Inc (MED)
This section provides a real-time view of insider transactions for Medifast Inc (MED). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MEDIFAST INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MEDIFAST INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 03
2022
|
Daniel R Chard Chairman & CEO |
SELL
Bona fide gift
|
Direct |
12,539
-44.38%
|
-
|
|
Dec 31
2021
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,533
-28.99%
|
$2,410,397
$209.43 P/Share
|
|
Dec 31
2021
|
Daniel R Chard Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,072
+37.7%
|
-
|
|
Nov 11
2021
|
Kevin G Byrnes Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,149
-29.18%
|
$1,401,972
$228.45 P/Share
|
|
Nov 11
2021
|
Kevin G Byrnes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,917
+21.25%
|
$361,676
$28.58 P/Share
|
|
Nov 08
2021
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
4,199
+1.25%
|
$961,571
$229.55 P/Share
|
|
Nov 04
2021
|
Daniel R Chard Chairman & CEO |
BUY
Bona fide gift
|
Indirect |
90,610
+50.0%
|
-
|
|
Nov 04
2021
|
Daniel R Chard Chairman & CEO |
SELL
Bona fide gift
|
Direct |
90,610
-85.22%
|
-
|
|
Sep 13
2021
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
109
+50.0%
|
-
|
|
Aug 20
2021
|
Kevin G Byrnes Director |
SELL
Open market or private sale
|
Direct |
673
-7.62%
|
$148,733
$221.99 P/Share
|
|
Aug 06
2021
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
142
+0.46%
|
$40,612
$286.16 P/Share
|
|
Jul 20
2021
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-5.84%
|
$31,855
$277.0 P/Share
|
|
Jul 07
2021
|
Jeffrey J Brown Director |
BUY
Bona fide gift
|
Indirect |
1,970
+6.05%
|
-
|
|
Jul 07
2021
|
Jeffrey J Brown Director |
SELL
Bona fide gift
|
Direct |
1,970
-72.03%
|
-
|
|
Jul 02
2021
|
Constance J. Hallquist |
SELL
Open market or private sale
|
Direct |
542
-7.76%
|
$154,470
$285.09 P/Share
|
|
Jun 17
2021
|
Daniel R Chard Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,365
-0.53%
|
$1,680,360
$264.62 P/Share
|
|
Jun 16
2021
|
Daniel R Chard Chairman & CEO |
SELL
Open market or private sale
|
Direct |
5,824
-0.63%
|
$1,595,776
$274.7 P/Share
|
|
Jun 15
2021
|
Daniel R Chard Chairman & CEO |
SELL
Open market or private sale
|
Direct |
7,696
-0.69%
|
$2,147,184
$279.4 P/Share
|
|
Jun 14
2021
|
Daniel R Chard Chairman & CEO |
SELL
Open market or private sale
|
Direct |
7,079
-0.49%
|
$2,003,357
$283.97 P/Share
|
|
Jun 11
2021
|
Daniel R Chard Chairman & CEO |
SELL
Open market or private sale
|
Direct |
8,036
-0.97%
|
$2,330,440
$290.09 P/Share
|
|
Jun 03
2021
|
Jeffrey J Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
765
+21.86%
|
-
|
|
Jun 03
2021
|
Kevin G Byrnes Director |
BUY
Grant, award, or other acquisition
|
Direct |
650
+6.86%
|
-
|
|
Jun 03
2021
|
Constance J. Hallquist |
BUY
Grant, award, or other acquisition
|
Direct |
679
+8.86%
|
-
|
|
Jun 03
2021
|
Michael A. Hoer Director |
BUY
Grant, award, or other acquisition
|
Direct |
650
+14.67%
|
-
|
|
Jun 03
2021
|
Scott Schlackman Director |
BUY
Grant, award, or other acquisition
|
Direct |
669
+10.18%
|
-
|
|
Jun 03
2021
|
Andrea B Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
659
+19.11%
|
-
|
|
May 19
2021
|
Scott Schlackman Director |
SELL
Open market or private sale
|
Direct |
1,000
-8.29%
|
$310,000
$310.83 P/Share
|
|
May 06
2021
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
179
+0.62%
|
$40,275
$225.04 P/Share
|
|
Mar 17
2021
|
Daniel R Chard Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,495
+3.74%
|
-
|
|
Mar 17
2021
|
James P. Maloney Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
776
+28.28%
|
-
|
|
Mar 17
2021
|
Stephen Kyle Johnson VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
272
+29.03%
|
-
|
|
Mar 03
2021
|
Constance J. Hallquist |
SELL
Open market or private sale
|
Direct |
4,500
-41.65%
|
$1,165,500
$259.02 P/Share
|
|
Mar 03
2021
|
Constance J. Hallquist |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+18.87%
|
$126,000
$28.14 P/Share
|
|
Feb 20
2021
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.0%
|
$268
$268.23 P/Share
|
|
Feb 19
2021
|
Stephen Kyle Johnson VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
43
-9.86%
|
$11,524
$268.23 P/Share
|
|
Feb 19
2021
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.0%
|
$268
$268.23 P/Share
|
|
Feb 05
2021
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
132
+0.46%
|
$31,680
$240.99 P/Share
|
|
Jan 14
2021
|
Kevin G Byrnes Director |
SELL
Bona fide gift
|
Direct |
2,000
-19.65%
|
-
|
|
Nov 06
2020
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
198
+0.69%
|
$31,680
$160.38 P/Share
|
|
Oct 01
2020
|
Michael C Macdonald Director |
SELL
Open market or private sale
|
Direct |
5,000
-0.37%
|
$825,000
$165.41 P/Share
|
|
Dec 01
2017
|
Welling Glenn W. Director |
SELL
Open market or private sale
|
Indirect |
275,000
-50.86%
|
$17,600,000
$64.6 P/Share
|
|
Nov 13
2017
|
Welling Glenn W. Director |
SELL
Open market or private sale
|
Indirect |
250,000
-35.95%
|
$16,250,000
$65.0 P/Share
|